Skip to main content
. 2021 Jun 22;12:360. doi: 10.1186/s13287-021-02435-1

Fig. 3.

Fig. 3

Background information on cells used in clinical trials. A Sources of the tissue from which MSCs were derived. B Reported use of autologous and allogeneic MSCs. C Nomenclature used to describe the cells used in the clinical trials